<DOC>
	<DOCNO>NCT02353000</DOCNO>
	<brief_summary>Recently stereotactic radiosurgery ( SRS ) 5 10 brain metastasis show equal survival 2 4 brain metastasis . Whole brain radiotherapy ( WBRT ) currently gold standard patient 3 brain metastasis , significant side effect . In prospective randomized phase III trial WBRT compare SRS patient 4 10 BM .</brief_summary>
	<brief_title>Whole Brain Radiotherapy ( WBRT ) Versus Stereotactic Radiosurgery ( SRS ) 4 Upto 10 Brain Metastases</brief_title>
	<detailed_description>Dutch guideline advice stereotactic radiosurgery ( SRS ) patient 1 3 brain metastasis ( BM ) whole brain radiotherapy ( WBRT ) patient 4 BM . The interim analysis QUARTZ study show WBRT provide benefit quality life survival best supportive care . WBRT significant side effect , hair loss , fatigue , cognitive dysfunction may impair quality life . A recently publish study show SRS patient 5 10 BM comparable survival patient treat 2 4 BM . Many systemic therapy satisfactory intracranial response , blood-brain barrier . The potential advantage SRS i.e , limit radiation dos uninvolved brain high rate local tumour control single treatment . Next logic step would compare WBRT SRS alone patient 4-10 BM evaluate whether SRS superior WBRT regard QOL .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Minimal 4 maximum 10 BM diagnostic MRI scan Max diameter single GTV 2.5cm Max cumulative GTV 30cm3 Karnofsky performance status â‰¥ 70 Any solid primary tumour . Small cell lung carcinoma , germinoma , lymphoma exclude Ability provide write informed consent Contraindication MRI Prior treatment BM ( i.e . surgery , SRS WBRT ) Concurrent use systemic therapy Maximum cumulative GTV 30cm3 planningMRI More 10 BM planningMRI A brainstem metastasis PTV 20 cm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>